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General Experimental
All reactions involving moisture sensitive reagents were carried out under a nitrogen atmosphere using standard vacuum line techniques and glassware that was flame dried. Solvents were dried following the procedure outlined by Grubbs & co-workers. 2 Water was deionized by an Elga DV 25 system. All other solvents and reagents were used as supplied (analytical or HPLC grade) without prior purification. Organic layers were dried over Na 2 SO 4 or MgSO 4 . Parallel work-ups were carried out using a Radleys stacker and Isolute phase separation cartridges. Thin layer chromatography was performed on aluminium plates coated with 60 F 254 silica gel. Plates were visualised using UV light (254 nm) or 1% aq. KMnO 4 . Flash column chromatography was performed on a Biotage Isolera One flash column chromatography platform unless stated. Purification by HPLC was performed using a Waters SFO with 515 HPLC pump and Waters Binary Gradient 2545 device (5%-95% solvent A (18% water, 80% acetonitrile, 2% 0.5 M ammonium acetate pH 6.0) in solvent B (93% water, 5% acetonitrile, 2% ammonium acetate pH 6.0)). Product was detected using a SQ Detector 2 and collected using a Waters Sample Manager 2767. Melting points were recorded on a Stuart SMP40 apparatus or a Barnstead Electrothermal 9100 machine and are uncorrected. IR spectra were recorded on a Nicolet iS5 with an iD7 ATR module, neat. Selected characteristic peaks are reported in cm -1 . NMR spectra were recorded on a Bruker Avance spectrometer or Varian spectrometer in the deuterated solvent stated. The field was locked by external referencing to the relevant deuteron resonance. Chemical shifts (δ) are reported in ppm and coupling constants (J) in Hz. Spectra were recorded at room temperature unless otherwise stated. Coupling constants (J) are quoted in Hz and are recorded to the nearest 0.1 Hz. When peak multiplicities are reported, the following abbreviations are used: s = singlet, d = doublet, t = triplet, m = multiplet, br = broadened, dd = doublet of doublets, dt = doublet of triplets.m/z values are reported in Daltons. Compound purity was assessed by elemental analysis (Elemental Analysis Service, London Metropolitan Univerisity) or by LCMS using either UV absorbance at 254 nm (Waters UV/Visible Detector 2489), ELSD signal (Waters ELS Detector 2424) or ESI+ TIC (SQ Detector 2). The detection method was chosen which gave the strongest signal. LCMS t r are quoted to the nearest 0.1 min. LCMS was performed on the following system: Kinetex 5µ EVO C18 100A 100 x 3.0 mm column using a linear gradient of solvent A (93 % H 2 O, 5 % acetonitrile, and 2 % of 0.5 M ammonium acetate pH 6.0) and solvent B (18 % H 2 O, 80 % acetonitrile, and 2 % of 0.5 M ammonium acetate pH 6.0), eluting at a flow rate of 2 mL/min: 5% B over 0.35 min, 5% B to 95% B over 1 min, 95% B over 0.75 min, 95% to 5% B over 0.1 min and 5% B over 0.8 min. LRMS were recorded by LCMS on a Waters SQ Detector 2; data acquisition and processing was performed using Waters FractionLynx software. HRMS was performed by the EPSRC UK National Mass Spectrometry Facility, University of Swansea using HNESP or run on a Agilent 6530 Accurate Mass Q-TOF; data acquisition and processing was performed using Agilent MassHunter Workstation software.
General Synthetic Procedures
General Procedure 1: Thiourea synthesis using 1,1′-Thiocarbonyldiimidazole 3 The first amine (0.6 mmol, 1.0 eq) was added to a stirred solution of 1,1′-thiocarbonyldiimidazole (100 mg, 0.6 mmol, 1.0 eq) in CH 2 Cl 2 (2 mL). The reaction mixture was stirred for 1-2 h at room temperature. The second amine (0.6 mmol, 1.0 eq) was added to the reaction mixture and stirred overnight at room temperature. The crude product was washed with aq. HCl (1M, 5 mL) and water (5 mL). The organic layer was dried and purified by flash column chromatography (12%-100% EtOAc in Cyclohexane). Solvent was removed in vacuo to afford the desired product.
General Procedure 2:
Amide coupling between an acyl chloride and an amine The amine (0.5 mmol, 1.0 eq) and triethylamine (224 µL, 1.6 mmol, 3 eq) were dissolved in CH 2 Cl 2 (2 mL). The acyl chloride (0.6 mmol, 1.05 eq) was added and the resulting reaction mixture stirred overnight at room temperature. The crude mixture was diluted with aq. NaOH (10%, 5 mL). The organic layer was separated, washed with water (5 mL) and dried. The solvent was removed in vacuo to afford the desired product.
General Procedure 3:
Oxazole formation from an acyl chloride and aminomalononitrile 4-toluenesulfonate 1 In a 35 mL microwave tube equipped with a magnetic stirrer, aminomalononitrile 4-toluenesulfonate (1.17 g, 4.60 mmol, 1.0 eq), N-methylpyrrolidone (12 mL) and the acyl chloride (5.06 mmol, 1.1 eq) were added. The vessel was then sealed using a rubber microwave septum and then placed into the microwave cavity. The reaction mixture was irradiated with 200 W of power and heated to 120°C for 20 min (dynamic profile with cooling). When at 120°C it was held by moderation of power for 20 min. The vessel was then cooled to room temperature. The reaction mixture was extracted with ethyl acetate (100 mL) and was initially washed with deionised water (2x100 mL), followed by sat. Na 2 CO 3 (2 x 100 mL). The organic layer was then dried with MgSO 4, filtered using fluted filter paper and the solvent removed in vacuo. Using a combiflash R75 the crude reaction mixture was purified using 2:8 ethyl acetate/ CH 2 Cl 2 as the elutant to give the desired product.
General Procedure 4: Urea synthesis using potassium cyanate
The amine (0.7 mmol, 1.0 eq) was added to a stirred solution of potassium cyanate (60 mg, 0.7 mmol, 1.0 eq) in acetic acid (1 mL, 1.3 mmol, 1.7 eq). The reaction mixture was stirred for 5 h at room temperature. The reaction mixture was filtered and the filtrand purified by reverse phase HPLC. Solvent was removed in vacuo to afford the desired product.
The synthesis and characterisation of compounds 18, 20, 21, s38 and s41-s46 are all described in Tetrahedron Letters, 2012, 53, 1656-1659. 1 LCMS traces and NMR spectras for all compounds described below are included in the supplementary material.
Chemistry Experimental
1-(o-tolyl)thiourea 1
Following General Procedure 1, 1,1′-thiocarbonyldiimidazole (166 mg, 0.9 mmol, 1.0 eq) was treated with o-toluidine (99 µL, 0.9 mmol, 1.0 eq) followed by ammonia methanol solution (133 µL, 7 M, 1.0 eq) to afford thiourea 1 as white crystals (102 mg, 13 (5) Following General Procedure 1, 1,1′-thiocarbonyldiimidazole (100 mg, 0.6 mmol, 1.0 eq) was treated with 2-methyl-3-methoxyaniline (78 mg, 0.6 mmol, 1.0 eq) followed by ammonia methanol solution (81 µL, 7 M, 1.0 eq). The crude reaction mixture was filtered and the filtrate collected to afford thiourea 5 as a white powder (79 mg, 71%). Following General Procedure 1, 1,1′-thiocarbonyldiimidazole (100 mg, 0.6 mmol, 1.0 eq) was treated with 2,3-dimethylaniline (74 µL, 0.6 mmol, 1.0 eq) followed by ammonia methanol solution (81 µL, 7 M, 1.0 eq) to afford thiourea 6 as a white powder ( 
1-(2-Methyl-3-(trifluoromethyl)phenyl)thiourea 7
Following General Procedure 1, 1,1′-thiocarbonyldiimidazole (100 mg, 0.6 mmol, 1.0 eq) was treated with 2-methyl-3-trifluoromethylaniline (99 mg, 0.6 mmol, 1. Following General Procedure 1, 1,1′-thiocarbonyldiimidazole (100 mg, 0.6 mmol, 1.0 eq) was treated with 2,6-dimethylaniline (70 µL, 0.6 mmol, 1.0 eq) followed by ammonia methanol solution (81 µL, 7 M, 1.0 eq) to afford thiourea 9 as a white powder ( 
1-Methyl-3-(o-tolyl)thiourea 10
Following General Procedure 1, 1,1′-thiocarbonyldiimidazole (100 mg, 0.6 mmol, 1.0 eq) was treated with methanamine hydrochloride (63 mg, 0.9 mmol, 1 eq) and triethylamine (143 µL, 1.0 mmol, 1. 
1-(2-Chlorophenyl)-3-methylthiourea 11
Following General Procedure 1, 1,1′-thiocarbonyldiimidazole (100 mg, 0.6 mmol, 1.0 eq) was treated with 2-chloroaniline (60 µL, 0.6 mmol, 1.0 eq) and triethylamine (87 µL, 1.0 mmol, 1.1 eq) followed by methanamine hydrochloride (38 mg, 0.6 mmol, 1 eq) to afford thiourea 11 as an off-white powder (22 mg, 19% 13 C NMR (101 MHz, CDCl 3 ) δ 181.7 (C=S), 133.6 (C(1)), 130.9 (C(3)), 130.1 (C(2)), 128.3 (C(4)), 128.1 (C(5)), 127.0 (C (6) 
N-(2,6-Dimethoxybenzyl)acetamide 12
Following General Procedure 2, acetyl chloride (40 µL, 0.6 mmol, 1.05 eq) was treated with 2,6-dimethoxybenzylamine (90 mg, 0.5 mmol, 1.0 eq) and triethylamine (149 µL, (5) 
N-(2,6-Dichlorobenzyl)-2-hydroxyacetamide 13
Glycolic acid (43 mg, 0.6 mmol, 1.0 eq) was treated with N,N-dimthylpyridin-4-amine (7 mg, 0.06 mmol, 0.1 eq) and N-Ethyl-N'-(3-dimethylaminopropyl)carbodiimide hydrochloride (88 mg, 0.5 mmol, 0.8 eq) and added to a stirred solution of 2,6-dichlorobenzylamine (100 mg, 0.6 mmol, 1 eq) and triethylamine (79 µL, 0.6 mmol, 1.0 eq) in DMF (2 mL). The reaction mixture was stirred overnight at room temperature. The reaction mixture was diluted with EtOAc and washed with water (2 x 20 mL) and brine (20 mL). The crude mixture was purified by flash column chromatography (0-10% MeOH in CH 2 (5) 
N-(2,6-Dichlorobenzyl)-N-methylacetamide 14
Following General Procedure 2, acetyl chloride (40 µL, 0.6 mmol, 1.05 eq) was treated with N-methyl-2,6-dichlorobenzylamine hydrochloride (121 mg, 0.5 mmol, 1.0 eq) and triethylamine (224 µL, 1.6 mmol, 3.0 eq) to afford amide 14 as a yellow solid (103 mg, 83%). Rotamers 14a and 14b were found to be present in a 2:1 ratio by NMR. (5) 13 
N-(2,6-Dimethoxybenzyl)-2-hydroxyacetamide 15
Compound s48 (150 mg, 0.32 mmol, 1 eq) was treated with tetra-Nbutylammonium fluoride (1M in THF, 0.49 mL, 0.49 mmol, 1.5 eq) in THF (5 mL). The reaction mixture was stirred for 1 h at room temperature. The solvent was removed in vacuo and the crude mixture was purified by flash column chromatography (0-10% MeOH in CH 2 Cl 2 ). Pure fractions were collected and the solvent removed in vacuo to afford amide 15 as a white powder (55 mg, 75%). Mp 126.5-128 °C; v max (5) (5) 
1-Ethyl-3-(o-tolyl)thiourea s1
Following General Procedure 1, 1,1′-thiocarbonyldiimidazole (100 mg, 0.6 mmol, 1.0 eq) was treated with o-toluidine (60 µL, 0.6 mmol, 1.0 eq) followed by ethanamine tetrahydrofuran solution (284 µL, 2 M, 1.0 eq) to afford thiourea s1 as a white powder (82 mg, 74%). Mp 85-87 °C (Lit. 9 
1-Isopropyl-3-(o-tolyl)thiourea s2
Following General Procedure 1, 1,1′-thiocarbonyldiimidazole (100 mg, 0.6 mmol, 1.0 eq) was treated with o-toluidine (60 µL, 0.6 mmol, 1.0 eq) followed by isopropylamine (49 µL, 0.6 mmol, 1.0 eq) to afford thiourea s2 as a white powder (92 mg, 78%). 
1-(2-Hydroxyethyl)-3-(o-tolyl)thiourea s3
Following General Procedure 1, 1,1′-thiocarbonyldiimidazole (166 mg, 0.9 mmol, 1.0 eq) was treated with o-toluidine (99 µL, 0.9 mmol, 1.0 eq) followed by 2-aminoethanol (56 µL, 0.9 mmol, 1.0 eq) to afford thiourea s3 as white 
1,1-Dimethyl-3-(o-tolyl)thiourea s4
Following General Procedure 1, 1,1′-thiocarbonyldiimidazole (100 mg, 0.6 mmol, 1.0 eq) was treated with o-toluidine (60 µL, 0.6 mmol, 1.0 eq) followed by dimethylamine hydrochloride (46 mg, 0.6 mmol, 1.0 eq) and triethylamine (87 µL, 0.6 mmol, 1.1 eq) to afford thiourea s4 as a white powder (72 mg, 65% 13 
1-(2-Chlorophenyl)thiourea s5
Following General Procedure 1, 1,1′-thiocarbonyldiimidazole (100 mg, 0.6 mmol, 1.0 eq) was treated with 2-chloroaniline (60 µL, 0.6 mmol, 1.0 eq) followed by ammonia methanol solution (81 µL, 7 M, 1.0 eq) to afford thiourea s5 as a white powder (31 mg, 29%). Mp 114. 1) ), 129.9 (C(3)), 129.7 (C(6)), 129.6 (C(2)), 127.7 (C(4)), 127.6 (C (5) 
1-(2-Methoxyphenyl)thiourea s6
Following General Procedure 1, 1,1′-thiocarbonyldiimidazole (100 mg, 0.6 mmol, 1.0 eq) was treated with 2-methoxyaniline (64 µL, 0.6 mmol, 1. 
1-(2,4-Dimethylphenyl)thiourea s8
Following General Procedure 1, 1,1′-thiocarbonyldiimidazole (100 mg, 0.6 mmol, 1.0 eq) was treated with 2,4-dimethylaniline (70 µL, 0.6 mmol, 1.0 eq) followed by ammonia methanol solution (81 µL, 7 M, 1.0 eq) to afford thiourea s8 as a white powder (33 mg, 32% C(2 or 4) ), 134.9 (C(1)), 134.8 (C(2 or 4) ), 131.6 (C(3 or 5) ), 127.9 (C (6) Following General Procedure 1, 1,1′-thiocarbonyldiimidazole (100 mg, 0.6 mmol, 1.0 eq) was treated with 3-chloro-2,6-dimethylanilne (88 mg, 0.6 mmol, 1.0 eq) followed by ammonia methanol solution (81 µL, 7 M, 1.0 eq) to afford thiourea s13 as a white powder (44 mg, 36%). Rotamers s13a and s13b were found to be present in a 3:2 ratio by NMR. 13 
1-(2,3-Dimethylphenyl)-3-methylthiourea s14
Following General Procedure 1, 1,1′-thiocarbonyldiimidazole (100 mg, 0.6 mmol, 1.0 eq) was treated with 2,3-dimethylaniline (74 µL, 0.6 mmol, 1.0 eq) followed by methanamine hydrochloride (38 mg, 0.6 mmol, 1.0 eq) and triethylamine (87 µL, 0.62 mmol, 1.1 eq) to afford thiourea s14 as a white powder (37 mg, 33%). Mp 173-174 °C (Lit. 13 
1-(3-Chloro-2-methylphenyl)-3-methylthiourea s15
Following General Procedure 1, 1,1′-thiocarbonyldiimidazole (100 mg, 0.6 mmol, 1.0 eq) was treated with 3-chloro-2-methylaniline (68 µL, 0.6 mmol, 1.0 eq) followed by methanamine hydrochloride (38 mg, 0.6 mmol, 1.0 eq) and triethylamine (87 µL, 0.62 mmol, 1.1 eq) to afford thiourea s15 as a white powder (53 mg, 44%). 
1-(2-Methoxyphenyl)-3-methylthiourea s16
Following General Procedure 1, 1,1′-thiocarbonyldiimidazole (100 mg, 0.6 mmol, 1.0 eq) was treated with 2-methoxyaniline (64 µL, 0.6 mmol, 1.0 eq) followed by methanamine hydrochloride (38 mg, 0.6 mmol, 1.0 eq) and triethylamine (87 µL, 0.62 mmol, 1.1 eq) to afford thiourea s16 as a white powder (52 mg, 47%). Mp 141.5-142.5 °C (Lit. 8 
1-(2-Methoxy-6-methylphenyl)-3-methylthiourea s18
Following General Procedure 1, 1,1′-thiocarbonyldiimidazole (100 mg, 0.6 mmol, 1.0 eq) was treated with 2-methoxy-6-methylaniline (78 mg, 0.6 mmol, 1.0 eq) followed by methanamine hydrochloride (38 mg, 0.6 mmol, 1.0 eq) and triethylamine (87 µL, 0.62 mmol, 1.1 eq) to afford thiourea s18 as an off-white powder (57 mg, 48%). Following General Procedure 1, 1,1′-thiocarbonyldiimidazole (100 mg, 0.6 mmol, 1.0 eq) was treated with 3-chloro-2,6-dimethylaniline (88 mg, 0.6 mmol, 1.0 eq) followed by methanamine hydrochloride (38 mg, 0.6 mmol, 1.0 eq) and triethylamine (87 µL, 0.62 mmol, 1.1 eq) to afford thiourea s19 as a white powder (16 
1-(2,3-Dimethylphenyl)urea s22
Following General Procedure 4, 2,3-dimethylaniline (96 µL, 0.7 mmol, 1.0 eq) was treated with potassium cyanate and acetic acid to afford urea s22 as a pink powder (59 mg, 49% Following General Procedure 4, 2-methoxy-6-methylaniline (60 mg, 0.7 mmol, 1.0 eq) was treated with potassium cyanate and acetic acid to afford urea s27 as a white powder (25 mg, 19% 
N-(2,6-Dichlorobenzyl)propionamide s29
Following General Procedure 2, propionyl chloride (52 µL, 0.6 mmol, 1.05 eq) was treated with 2,6-dichlorobenzylamine (100 mg, 0.6 mmol, 1.0 eq) and triethylamine (158 µL, 1.1 mmol, 2.0 eq) to afford amide s29 as a white powder (108 mg, 82%). (5) 
N-(2,6-Dichlorobenzyl)isobutyramide s30
Following General Procedure 2, isobutyryl chloride (62 µL, 0.6 mmol, 1.05 eq) was treated with 2,6-dichlorobenzylamine (100 mg, 0.6 mmol, 1.0 eq) and triethylamine (158 µL, 1.1 mmol, 2.0 eq) to afford amide s30 as a white powder (114 mg, 82%). (5) 
N-(2,6-Dichlorobenzyl)-2,2,2-trifluoroacetamide s31
Ethyl 2,2,2-trifluoroacetate (135 µL, 1.1 mmol, 2.0 eq) and triethylamine (79 µL, 0.6 mmol, 1.0 eq) were added to a stirred solution of 2,6-dichlorobenzylamine (100 mg, 0.6 mmol, 1.0 eq) in MeOH (1 mL). The reaction mixture was stirred overnight at room temperature. The solvent was removed in vacuo and the crude solid dissolved in EtOAc. The solution was washed with water (2 x 20 mL) and brine (20 mL). The organic layer was dried and the solvent removed in vacuo to afford amide s31 as a white powder (103 mg, 67%). 
N-(2-Chloro-5-(trifluoromethyl)benzyl)acetamide s37
Following General Procedure 2, acetyl chloride (40 µL, 0.6 mmol, 1.05 eq) was treated with 2-chloro-5-trifluoromethylbenzylamine (75 µL, 0.5 mmol, 1.0 eq) and triethylamine (149 µL, 1.0 mmol, 2.0 eq) to afford amide s37 as a yellow solid (98 mg, 65%). Assays were performed as described previously 19 with minor modifications from the manufacturer's protocol (PerkinElmer, USA). All reagents were diluted in 25 mM HEPES, 100 mM NaCl, 0.1 % BSA, pH 7.4 supplemented with 0.05 % CHAPS and allowed to equilibrate to room temperature prior to addition to Crystallisation PHIPA(2) Brd was crystallized by mixing 100nl of 13mg/ml protein in 20mM HEPES pH7.5, 500mM NaCl, 5% Glycerol with 100nl of reservoir solution containing 0.1M HEPES pH 7.5, 0.15M Magnesium Chloride, 34% PEG3350. Crystals appeared overnight from sitting drop plates at 4°C. PHIP(2) Brd crystallized in space group P2 1 2 1 2 with typical unit cell dimensions of a=60Å, b=92Å, c=24Å, corresponding to one PHIP(2) Brd molecule in the asymmetric unit.
Compound Soaking
All compounds of DSPL0 were dissolved in ethylene glycol at a nominal concentration of 400mM. It should be noted that not all compounds could be dissolved at such high concentrations, but in this case we assumed that the solution was saturated. 600nl of each compound was mixed with 600nl of reservoir solution and the mixture was added to the crystals by using a Mosquito® crystallization robot (TTP Labtech). The plates were resealed and incubated for at least 12 hours at 4°C before the crystals were mounted in nylon loops and immediately flash frozen in liquid nitrogen.
Data Collection and Structure Solution
All datasets were collected on beamline I04-1 at the Diamond Light Source. Data were integrated and scaled with XIA2 20 which is part of the Diamond Light Source autoprocessing pipeline. 21 Initial electron density maps were calculated with DIMPLE 22 and inspected with COOT. 23 Once a hit was identified, further rounds of refinement with REFMAC 24 and manual rebuilding with COOT were carried out. ACEDRG 22 was used to generate compound coordinates and restraint files. The quality of the final models was validated with MOLPROBITY. 25 Statistics for data collection and refinement are summarized in supplementary table 4. Design of DSPL1 (Diamond-SGC Poised Fragment Library v1.0) DSPL1 was designed using the same algorithms as explained above. Fragment libraries already owned by Diamond and the SGC were mined for poised fragments.
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Design of DSPL2 (Diamond-SGC Poised Fragment Library v 2.0)
Commercial poised fragments were identified using a workflow prepared using Schrodinger extensions for KNIME (2.6.4 workbench version 2.5.1 v15901 from the Schrodinger 2012 Suite). [26] [27] [28] To build DSPL2, the ZINC Fragment-Like library (clogP ≤ 3.5, MW ≤ 250, rotatable bonds ≤ 5) was used. 29, 30, 31 The library contained 701,228 compounds in SMILES format. 192,151 compounds were selected based upon their commercial availability from vendors we routinely source compounds from. Rapid elimination of swill (REOS) was performed using sub-structure matching nodes to ensure drug-like characteristics and remove known toxic and promiscuous functionalities. 32 The resulting fragment library contained 41,271 compounds.
Fragments were filtered for poised functional groups using the substructures defined in Figure 4A . By this definition, 28,438 fragments were found to be poised, covering 42,997 reactions with a large number of fragments being found to be poised via multiple reaction types. Each fragment was deconstructed into two synthons and kept if both starting materials were believed to be commercially available. Of the >28,000 fragments, 11,875 poised fragments (42%) were believed to have two, well-represented commercially available starting synthons, covering 15,277 reactions.
Further filters were applied to remove compounds without ring systems, 33 with quaternary nitrogens or containing imines and diacyl hydrazides. In total, 1,347 compounds were removed, leaving a library of 10,448 fragments.
The Knime protocol used to build DSPL1 and DSP2 can be downloaded as zip files with the electronic supplementary material.
The full DSPL1 and DSPL2 libraries can be downloaded in sdf format with the electronic supplementary information.
